ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Enrylaze 10 mg/vial, Injektionslösung - 3
69073001 MEDA Pharmaceuticals Switzerland GmbH
Enrylaze 10 mg/vial, Injektionslösung18.04.2024
  18.04.2024
Asparaginase (L01XX02) 
WHO-DDD17.04.2029
3
07.16.10. 
A  
No 
  
PR  
k.A.PR
  
7680690730017Biotechnologika
  
Composition
crisantaspasum 10 mg, trehalosum dihydricum, natrii chloridum, dinatrii phosphas, dinatrii phosphas monohydricus, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp. natrium ca. 1 mg.
Packungsbestandteile
Injection solution
 
 
Active AgentDose
Crisantaspasum10mg / 0.5ml
 
Inactive agents
Disodium Phosphate
Dinatrii Phosphas Monohydricus
Sodium Chloride
Sodium Hydroxide
Polysorbatum 80
Trehalosum Dihydricum
Source
Data was imported : 04.05.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home